Profile
Nancy Veulemans formerly worked at ClinTrials Research, Inc., as Principal, BruCells NV, as Head-Regulatory Affairs from 2005 to 2012, Cyanamid International Corp., as Product Manager, and Bristol Myers International Group, as Principal.
Ms. Veulemans received her graduate degree from Université Catholique de Louvain.
Former positions of Nancy Veulemans
| Companies | Position | End |
|---|---|---|
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | General Counsel | 21/11/2012 |
| Cyanamid International Corp. | Corporate Officer/Principal | - |
ClinTrials Research, Inc.
 ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Corporate Officer/Principal | - |
| Bristol Myers International Group | Corporate Officer/Principal | - |
Training of Nancy Veulemans
| Université Catholique de Louvain | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
ClinTrials Research, Inc.
ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Commercial Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Health Technology |
| Cyanamid International Corp. | |
| Bristol Myers International Group |
- Stock Market
- Insiders
- Nancy Veulemans
